NCT04005807View on ClinicalTrials.gov

Safety and Tolerability of Escalating Doses of BPN-14967 in Healthy Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

July 19, 2019

Primary Completion Date

December 20, 2019

Study Completion Date

December 20, 2019

Conditions

Healthy Volunteers

Interventions

DRUG

BPN-14967

BPN-14967 oral capsules

DRUG

Placebo

Oral capsules

Trial Locations (1)

78744

PPD Phase I Clinic, Austin

Sponsors

Lead Sponsor

Belite Bio, Inc

All Listed Sponsors

lead

Belite Bio, Inc

INDUSTRY